Utility of Transgenic Mice Carrying Human Prototype c-Ha-im Gene for Alternative Carcinogenicity Testing of Chemicals - Negative Results with Methapyrilene Hydrochloride

Journal of Toxicologic Pathology

Volumn 13, Issue 3, 2000, Pages 179-188

  Ogasawara, Hiroyuki ^a,b   Tsutsumi, Masahiro ^a   Takeda, Kazunori ^b   Usui, Koji ^b   Kobayashi, Hiroyuki ^b   Murakami, Hisako ^b   Takagi, Hidetoshi ^b   Kumagai, Toshio ^b   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Wyeth Lederle Japan Ltd   (Japan)

Author keywords

Human c Ha ras gene; Methapyrilene hydrochloride; RasH2 mouse; Short term carcinogenicity test

Indexed keywords

EID: 0001313710     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.13.179     Document Type: Article

References (37)

1. Davies TS and Monro A. Marketed human pharmaceuticals reported to be tumorigenic in rodents. J Am Coll Toxicol 1995; 14: 90-107.
2. Tennant RW, French JE, and Spalding JW. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Health Perspect 1995; 103: 942-950.
3. Storer RD, Cartwright ME, Cook WO, Soper KA, and Nichols WW. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice. Carcinogenesis 1995 ; 16: 285-293.
4. De Vries A, Van Oostrom CThM, Hofhuis FMA, Dortant PM, Berg RJW, De Gruijl FR, Wester PW, Van Kreijl CF, Capel PJA Van Steeg H, and Verbeek SJ. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 1995 ; 377 : 169-173.
5. Yamamoto S, Mitsumori K, Kodama Y, Matsunuma N, Manabe S, Okamiya H, Suzuki H, Fukuda T, Sakamaki Y, Sunaga M, Nomura G, Hioki K, Wakana S, Nomura T, and Hayashi Y. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-trans -genie mice. Carcinogenesis 1996; 17: 2455-2461.
6. Robinson D. The international Life Sciences Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol Pathol 1998 ; 26: 474-475.
7. Saitoh A, Kimura M, Takahashi R, Yokoyama M, Nomura T, Izawa M, Sekiya T, Nishimura S, and Katsuki M. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 1990; 5: 1195-1200.
8. Mitsumori K, Koizumi H, Nomura T, and Yamamoto S. Pathological Features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol 1998; 26: 520-531.
9. Yamamoto S, Urano K, Koizumi H, Wakana S, Hioki K, Mitsumori K, Kurokawa Y, Hayashi Y, and Nomura T. Validation of transgenic mice carrying the human prototype cHa-ras gene as a bioassay model for rapid carcinogenicity testing. Environ Health Perspect 1998; 106: 57-69.
10. Lijinsky W, Reuber MD, and Blackwell BN. Liver tumors induced in rats by oral administration of the antihistamic methapyrilene hydrochloride. Science 1980; 209: 817-819.
11. Lijinsky W, Knutsen G, and Reuber MD. Failure of methapyrilene to induce tumors in hamsters or guinea pigs. J Tox Environ Health 1983 ; 12: 653-657.
12. Brennan LM and Creasia DA. The effects of methapyrilene hydrochloride on hepatocarcinogenicity and pentobarbitalinduced sleeping time in rats and mice. Toxicol Appl Pharmacol 1982; 66: 252-258.
13. Mirsalis JC. Genotoxicity, toxicity, and carcinogenicity of the antihistamine methapyrilene. Mutat Res 1987; 185: 309-317.
14. Murata A, Shimoji N, Ogasawara H, Murakami H, Komatsu H, Iwashima K, Nakata S, and Takagi H. New fixation method of the testes in rats. Jan J Histotechnol 1993 ; 2 : 87-91.
15. Andrews AW, Fornwald JA, and Lijinsky W. Nitrosation and mutagenicity of some amine drugs. Toxicol Appl Pharmacol 1980; 52: 237-244.
16. Casciano DA, Shaddock JG, and Talaska G. The potent hepatocarcinogen methapyrilene does not form DNA adducts in livers of Fischer 344 rats. Mutat Res 1988 ; 208 : 129-135.
17. Lijinsky W and Yamashita K. Lack of binding of methapyrilene and similar antihistamines to rat liver DNA examined by 32P postlabeling. Cancer Res 1988 ; 48 : 6475-6477.
18. lype PT, Ray-Chaudhuri R, Lijinsky W, and Kelley SP. Inability of methapyrilene to induce sister chromatid exchanges in vitro and in vivo. Cancer Res 1982; 42: 4614-4618.
19. Casciano DA and Schol HM. Methapyrilene is inactive in the hepatocyte-mediated Chinese hamster ovary/hypoxanthineguanine phosphoribosyl transferase mutational assay. Cancer Lett 1984; 21: 337-341.
20. Steinmetz KL, Tyson CK, Meierhenry EF, Spalding JW, and Mirsalis JC. Examination of genotoxicity, toxicity, and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene. Carcinogenesis 1988; 9: 959-963.
21. Hatch GG, Anderson TM, Lubet RA, Kouri RE, Putman DL, Cameron JW, Nims RW, Most B, Spalding JW, Tennant RW, and Schechtman LM. Chemical enhancement of SA7 virus transformation of hamster embryo cells : Evaluation by interlaboratory testing of diverse chemicals. Environ Mutagen1986; 8: 515-531.
22. +/- mouse lymphoma assay. Mutat Res 1987; 189: 285-297.
23. Harnandez L, Petropoulos CJ, Hughes SH, and Lijinsky W. DNA methylation and oncogene expression in methapyrileneinduced rat liver tumors and in treated hepatocytes in culture. Mol Carcinogenesis 1991 ; 4: 203-209.
24. Ohshima M, Ward JM, Brennan LM, and Creasia DA. A sequential study of methapyrilene hydrochloride-induced liver Carcinogenesis in male F344 rats. JNCI 1984; 72: 759-768.
25. Lijinsky W. Chronic toxicity tests of pyrilamine maleate and methapyrilene hydrochloride in F344 rats. Fd Chem Toxic 1984 ; 22: 27-30.
26. Glauert HP and Pitot HC. Effect of the antihistamine, methapyrilene, as an initiator of hepatocarcinogenesis in female rats. Cancer Lett 1989; 46: 189-194.
27. Furuya K, Mori H, and Williams GM. An enhancing effect of the antihistaminic drug methapyrilene on rat liver carcinogenesis by previously administered N-2-fluorenylacetamide. Toxicol Appl Pharmacol 1983 ; 70 : 49-56.
28. Lijinsky W, Kovatch RM, and Thomas BJ. The carcinogenic effect of methapyrilene combined with nitrosodiethylamine given to rats in low doses. Carcinogenesis 1992 ; 13 : 1293-1297.
29. + staining foci by the rat hepatocarcinogen methapyrilene in the medium-term bioassay. Fundam Appl Toxicol 1996 ; 29 : 194-197.
30. Richardson FC, Copple DM, and Eacho PI. Effects of methapyrilene on DNA synthesis in mice and rats following continuous dietary exposure. Carcinogenesis 1992 ; 13 : 2453-2457.
31. Cunningham ML, Pippin LL, Anderson NL, and Wenk ML. The hepatocarcinogen methapyrilene but not the analog pyrilamine induces sustained hepatocellular replication and protein alterations in F344 rats in a 13-week feed study. Toxicol Appl Pharmacol 1995; 131: 216-223.
32. Reznik-Schuller HM and Lijinsky W. Morphology of early changes in liver Carcinogenesis induced by methapyrilene. Arch Toxicol 1981; 49: 79-83.
33. Perera MIR, Katyal SL, and Shinozuka H. Methapyrilene induces membrane lipid peroxidation of rat liver cells. Carcinogenesis 1985; 6: 925-927.
34. Cunningham ML. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutat Res 1996; 365: 59-69.
35. 2+ channel blocker verapamil. Toxicology 1998 ; 130 : 79-93.
36. Lampe MA and Kammerer RC. Species differences in the metabolism and macromolecular binding of methapyrilene : a comparison of rat, mouse and hamster. Xenobiotica 1990; 20: 1269-1280.
37. Kelly DW, Holder CL, Korfmacher WA, Getek TA, Lay JO, Casciano DA, Shaddock JG, Duhart HM, and Slikker Jr W. Metabolism of methapyrilen by Fischer-344 rat and B6C3F1 mouse hepatocytes. Xenobiotica 1992 ; 22 : 1367-1381.